PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 1 month ago Abivax annonce une modification de la composition de son Conseil d'administration Abivax annonce la démission du Dr. Philippe Pouletty en tant qu'administrateur et recherche un nouveau membre du Conseil d'administration pour soutenir le développement de thérapies. Détails sur www.abivax.com Innovation Abivax Conseil D'administration Démission Thérapies
PRESS RELEASE published on 12/23/2024 at 22:05, 1 year 1 month ago Abivax Announces a Change to the Composition of its Board of Directors Abivax announces a change in its Board of Directors composition as Dr. Philippe Pouletty resigns due to new appointment. The company expresses gratitude for his contributions Board Of Directors Resignation Abivax Therapeutics Dr. Philippe Pouletty
BRIEF published on 12/18/2024 at 18:05, 1 year 1 month ago ABIVAX : Capital social et droits de vote au 30 novembre 2024 Investissement Euronext Paris Droits De Vote Capital Social Abivax
BRIEF published on 12/18/2024 at 18:05, 1 year 1 month ago ABIVAX: Share capital and voting rights as of November 30, 2024 Euronext Paris Share Capital Voting Rights Abivax Investment
PRESS RELEASE published on 12/18/2024 at 18:00, 1 year 1 month ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.11.24. ABIVAX communique le nombre d'actions et de droits de vote au 30 novembre 2024 conformément aux dispositions réglementaires. Société de biotechnologie en développement clinique axée sur les traitements immunitaires Droits De Vote Biotechnologie Actions Abivax Développement Clinique
BRIEF published on 11/27/2024 at 18:05, 1 year 2 months ago ABIVAX : Actualisation du Capital Social et des Droits de Vote Euronext Paris Droits De Vote Capital Social Abivax Transparence Financière
BRIEF published on 11/27/2024 at 18:05, 1 year 2 months ago ABIVAX: Update of Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights Abivax Financial Transparency
PRESS RELEASE published on 11/27/2024 at 18:00, 1 year 2 months ago ABIVAX: Nombre d'actions composant le capital social et nombre total de droits de vote au 31.10.24. ABIVAX divulgue le nombre d'actions et de droits de vote au 31.10.24 conformément à la réglementation. Informations sur son capital social et son candidat médicament ABX464 Droits De Vote Capital Social Biotechnologie Abivax ABX464
BRIEF published on 11/19/2024 at 22:35, 1 year 2 months ago Abivax lance un programme ATM sur le Nasdaq Biotechnologie Financement Nasdaq Actions Ordinaires Programme ATM
BRIEF published on 11/19/2024 at 22:35, 1 year 2 months ago Abivax Launches ATM Program on Nasdaq Common Shares Biotechnology Funding Nasdaq ATM Program
Published on 02/03/2026 at 15:00, 1 hour 24 minutes ago Vox Royalty Announces Record 2025 Annual and Quarterly Receipts and Exceeds Annual Guidance
Published on 02/03/2026 at 14:29, 1 hour 55 minutes ago Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 2 hours 26 minutes ago QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 2 hours 54 minutes ago Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 2 hours 54 minutes ago Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA
Published on 02/03/2026 at 16:05, 19 minutes ago Enjin Launches Essence of the Elements: A Cross-Game Multiverse Journey
Published on 02/03/2026 at 08:30, 7 hours 54 minutes ago cegedim.cloud lance la nouvelle version d’Enercare, son module de calcul et de pilotage de l’empreinte carbone
Published on 02/03/2026 at 08:00, 8 hours 24 minutes ago EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 8 hours 24 minutes ago EURAZEO ET PANTHEON METTENT EN PLACE UN VÉHICULE DE CONTINUATION DE DETTE PRIVÉE DE PRÈS DE €500 MILLIONS
Published on 02/03/2026 at 08:00, 8 hours 24 minutes ago Neoen lance la construction de trois nouveaux parcs solaires en France pour une capacité totale de 230 MWc